In the Wall Street Investment Bible, I discussed other securities I that had a good chance of bankruptcy down the road (e.g. Blockbuster and Sirius Satellite). Regardless what ultimately happens with these companies, my analysis has thus far been correct. Since analyzing these companies, shares have declined by about 90%.
In the most recent newsletter, I discussed some stocks in the past that I was able to determine that the market was wrong about.
The reason why I mentioned this was to demonstrate my track record assessing distressed securities and securities facing challanges.
Why might it be important to gain confidence from subscribers in my abilities to assess distressed securities?
Because this is the best way to make a lot of money.
It's also one of the most risky.
Hundreds of stocks have been battered by the financial apocalypse. Thus, the ability to determine whether or not to invest in these stocks and when to invest has never been more important.
Most recently, Goldman Sachs and British Petroleum have seen big losses in market cap. At some point, investors might begin to question whether they represent tremendous value or tremendous risk.
Here, I show a summary of the argument I made for a stock that was seen as very questionable in the past, hoping to provide you will the basic process you need to follow if you want to seperate yourself from the herd. Of course, the following presentation is very simplified and does not include all of my analysis.
The company is Merck. You might recall in the fall of 2004, the Vioxx scandel broke.
Shares of Merck collapsed from over $50 to around $30.
A few weeks later, Mrk fell to the mid 20s. Panic was everywhere.
This article continues.
To continue viewing this entry please sign in to your Client or Member account.
Restrictions Against Reproduction: No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without the prior written permission of the copyright owner and the Publisher.
These articles and commentaries cannot be reposted or used in any publications for which there is any revenue generated directly or indirectly. These articles cannot be used to enhance the viewer appeal of any website, including any ad revenue on the website, other than those sites for which specific written permission has been granted. Any such violations are unlawful and violators will be prosecuted in accordance with these laws.
Article 19 of the United Nations' Universal Declaration of Human Rights: Everyone has the right to freedom of opinion and expression; this right includes freedom to hold opinions without interference and to seek, receive and impart information and ideas through any media and regardless of frontiers.
This publication (written, audio and video) represents the commentary and/or criticisms from Mike Stathis or other individuals affiliated with Mike Stathis or AVA Investment Analytics (referred to hereafter as the “author”). Therefore, the commentary and/or criticisms only serve as an opinion and therefore should not be taken to be factual representations, regardless of what might be stated in these commentaries/criticisms. There is always a possibility that the author has made one or more unintentional errors, misspoke, misinterpreted information, and/or excluded information which might have altered the commentary and/or criticisms. Hence, you are advised to conduct your own independent investigations so that you can form your own conclusions. We encourage the public to contact us if we have made any errors in statements or assumptions. We also encourage the public to contact us if we have left out relevant information which might alter our conclusions. We cannot promise a response, but we will consider all valid information.